[HTML][HTML] Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects
Sodium glucose cotransporter 2 inhibitors (SGLT2i) constitute a promising drug treatment for
heart failure patients with either preserved or reduced ejection fraction. Whereas SGLT2i …
heart failure patients with either preserved or reduced ejection fraction. Whereas SGLT2i …
Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects
JRB Dyck, S Sossalla… - Journal of …, 2022 - researchinformation.amsterdamumc …
Sodium glucose cotransporter 2 inhibitors (SGLT2i) constitute a promising drug treatment for
heart failure patients with either preserved or reduced ejection fraction. Whereas SGLT2i …
heart failure patients with either preserved or reduced ejection fraction. Whereas SGLT2i …
[引用][C] Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects
JRB Dyck, S Sossalla, N Hamdani, R Coronel… - Journal of Molecular …, 2022 - cir.nii.ac.jp
Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence
for potential off-target effects | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
for potential off-target effects | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
[引用][C] Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects
JRB Dyck, S Sossalla, N Hamdani, R Coronel… - 2022 - publications.goettingen-research …
Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects.
JRB Dyck, S Sossalla, N Hamdani… - Journal of Molecular …, 2022 - europepmc.org
Sodium glucose cotransporter 2 inhibitors (SGLT2i) constitute a promising drug treatment for
heart failure patients with either preserved or reduced ejection fraction. Whereas SGLT2i …
heart failure patients with either preserved or reduced ejection fraction. Whereas SGLT2i …
Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects
JRB Dyck, S Sossalla, N Hamdani… - … of molecular and …, 2022 - pubmed.ncbi.nlm.nih.gov
Sodium glucose cotransporter 2 inhibitors (SGLT2i) constitute a promising drug treatment for
heart failure patients with either preserved or reduced ejection fraction. Whereas SGLT2i …
heart failure patients with either preserved or reduced ejection fraction. Whereas SGLT2i …